Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James P Stevenson

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Phase I and pharmacokinetic trial of the novel taxane BMS-184476 administered as a 1-hour intravenous infusion in combination with cisplatin every 21 daysWeijing Sun, James P Stevenson, Maryann L Gallagher, et al.
American Journal of Clinical Oncology|April 22, 2016
Analysis of the Relationship Between Response to Chemotherapy and Response to Radiation Therapy in Patients With Non-Small Cell Lung Cancer Receiving Sequential TreatmentGenevieve Maquilan, Surbhi Grover, Eric Xanthopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2002
Phase I trial of the cryptophycin analogue LY355703 administered as an intravenous infusion on a day 1 and 8 schedule every 21 daysJames P Stevenson, Weijing Sun, Maryann Gallagher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Phase II trial of pleural photodynamic therapy and surgery for patients with non-small-cell lung cancer with pleural spreadJoseph S Friedberg, Rosemarie Mick, James P Stevenson, et al.
Plos One|October 26, 2018
Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patientsMonica Khunger, Pradnya Dinkar Patil, Arjun Khunger, et al.
Cancer Chemotherapy and Pharmacology|January 15, 2004
Phase I trial of the antifolate ZD9331 in combination with cisplatin in patients with refractory solid malignanciesJoshua H Bilenker, James P Stevenson, Keith T Flaherty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Phase I trial of combretastatin a-4 phosphate with carboplatinJoshua H Bilenker, Keith T Flaherty, Mark Rosen, et al.
Journal of Oncology Practice|January 14, 2016
Reduction of Inappropriate Prophylactic Pegylated Granulocyte Colony-Stimulating Factor Use for Patients With Non-Small-Cell Lung Cancer Who Receive Chemotherapy: An ASCO Quality Training Program Project of the Cleveland Clinic Taussig Cancer InstituteLindsey Martin Goodman, Machelle B Moeller, Abdel-Ghani Azzouqa, et al.
Cancer|May 1, 2012
Phase 2 trial of maintenance bevacizumab alone after bevacizumab plus pemetrexed and carboplatin in advanced, nonsquamous nonsmall cell lung cancerJames P Stevenson, Corey J Langer, Robert A Somer, et al.
Cancer|February 3, 2011
Adjuvant radiotherapy for completely resected stage 2 thymomaAbigail T Berman, Leslie Litzky, Virginia Livolsi, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Phase I and pharmacokinetic trial of the novel taxane BMS-184476 administered as a 1-hour intravenous infusion in combination with cisplatin every 21 daysWeijing Sun, James P Stevenson, Maryann L Gallagher, et al.
American Journal of Clinical Oncology|April 22, 2016
Analysis of the Relationship Between Response to Chemotherapy and Response to Radiation Therapy in Patients With Non-Small Cell Lung Cancer Receiving Sequential TreatmentGenevieve Maquilan, Surbhi Grover, Eric Xanthopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2002
Phase I trial of the cryptophycin analogue LY355703 administered as an intravenous infusion on a day 1 and 8 schedule every 21 daysJames P Stevenson, Weijing Sun, Maryann Gallagher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Phase II trial of pleural photodynamic therapy and surgery for patients with non-small-cell lung cancer with pleural spreadJoseph S Friedberg, Rosemarie Mick, James P Stevenson, et al.
Plos One|October 26, 2018
Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patientsMonica Khunger, Pradnya Dinkar Patil, Arjun Khunger, et al.
Cancer Chemotherapy and Pharmacology|January 15, 2004
Phase I trial of the antifolate ZD9331 in combination with cisplatin in patients with refractory solid malignanciesJoshua H Bilenker, James P Stevenson, Keith T Flaherty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Phase I trial of combretastatin a-4 phosphate with carboplatinJoshua H Bilenker, Keith T Flaherty, Mark Rosen, et al.
Journal of Oncology Practice|January 14, 2016
Reduction of Inappropriate Prophylactic Pegylated Granulocyte Colony-Stimulating Factor Use for Patients With Non-Small-Cell Lung Cancer Who Receive Chemotherapy: An ASCO Quality Training Program Project of the Cleveland Clinic Taussig Cancer InstituteLindsey Martin Goodman, Machelle B Moeller, Abdel-Ghani Azzouqa, et al.
Cancer|May 1, 2012
Phase 2 trial of maintenance bevacizumab alone after bevacizumab plus pemetrexed and carboplatin in advanced, nonsquamous nonsmall cell lung cancerJames P Stevenson, Corey J Langer, Robert A Somer, et al.
Cancer|February 3, 2011
Adjuvant radiotherapy for completely resected stage 2 thymomaAbigail T Berman, Leslie Litzky, Virginia Livolsi, et al.
Pageof 5